Skip to main content

Revealing and tackling the complexities of the tumour microenvironment

BSI event
T cells attacking orange cancer cell
Millennium Point, Birmingham
In person
Register here

The BSI Tumour Immunology Group is excited to present this two-day meeting that will bring together scientific and clinical researchers alongside industry partners to examine and interrogate the multifaceted role of the immune system in the tumour microenvironment, and discuss how to harness these complexities.

The BSI Tumour Immunology Group looks forward to welcoming you at Millennium Point in Birmingham on Thursday 14 and Friday 15 March 2024.

Please follow @bsicongress and check the event hashtag #TumourMicroenvironment24 for updates.

A range of invited and abstract speakers will explore a wide array of topics within this field:

  • The cellular diversity within the microenvironment, including the influence of ‘hidden players’, immune plasticity, and unconventional immune cells
  • The spatial dynamics of tumour microenvironment and the contribution of different immune priming sites
  • New models and technologies to study the immune response in the tumour microenvironment
  • Microenvironmental determinants of therapeutic responses, as well as novel immunotherapeutic modulators of the tumour microenvironment


Day 1

09:30 | Registration and refreshments

10:00 | Welcome address: Professor Ben Willcox (BSI Tumour Immunology Group)

SESSION 1 – Shaping the tumour microenvironment

Chairs: Professor Seth Coffelt (CRUK Scotland Institute, UK) and Dr Victoria Stavrou (University of Birmingham, UK)

10:10 | Invited speaker: Professor Gareth Thomas (University of Southampton, UK) 
Characterising immunological fibroblast subsets in cancer: opportunities for therapeutic targeting
10:45 | Selected short talk: Jamie Kwon (University of Oxford, UK)
Characterisation of the tumour microenvironment in homologous recombination-deficient prostate cancer
11:00 | Invited speaker: Dr Kendle Maslowski (CRUK Scotland Institute, UK) 
Bugs as drugs: Overcoming T cell dysfunction in bacterial cancer therapy
11:35 | Invited speaker: Professor Eileen Parkes (University of Oxford, UK)
cGAS driven inflammation in oesophageal adenocarcinoma
12:10 | Lunch, poster viewing and meet the exhibitors (poster viewing from 12:40–13:25)

SESSION 2 – Spatial dynamics and generating immune responses (part 1)

Chairs: Professor Shoba Amarnath (Newcastle University, UK) and Dr Richard Buchanan (University of Southampton, UK)

13:25 | Invited speaker: Dr Raza Ali (CRUK Cambridge Institute, UK) 
Highly multiplexed imaging for precision breast immuno-oncology
14:00 | Selected short talk: Lorenzo Capitani (Cardiff University, UK) 
A polyclonally expanded TCR repertoire in CD8 T cells is a strong correlate of tumour 
regression following Treg-targeted immunotherapy
14:15 | Selected short talk: Dr Matthew Pugh (University of Birmingham, UK) 
Multi-omic spatial profiling of the tumour microenvironment reveals correlates of 
malignant behaviour in Hogkin-like lymphoproliferations
14:30 | Invited speaker: Dr Leo Carlin (CRUK Scotland Institute, UK) 
4D regulation of myeloid cells in cancer
15:05 | Refreshment break and meet the exhibitors

SESSION 3 – Hidden immune players and therapeutic modulation (part 1)

Chairs: Professor Santiago Zelenay (University of Manchester, UK) and Ms Fernanda Escobar Riquelme (University of Birmingham, UK)

15:35 | Invited speaker: Dr Molly Ingersoll, (Institut Pasteur, France)
Why sex matters in immunity
16:10 | Selected short talk: Dr Charles Earnshaw (University of Manchester, UK) 
Glucocorticoids stimulate T cell-dependent melanoma growth control
16:25 | Industry sponsored talk: Filomena Spada (Standard BioTools, UK) 
High-plex whole slide spatial biology assays powered by the Hyperion XTi
16:35 | Invited speaker: Professor Andrew Sewell (Cardiff University, UK) 
What can we learn from successful clearance of solid cancer? 
17:10 | Closing remarks

17:15 | Networking reception

18:15 | Day 1 close

Day 2

09:00 | Registration and refreshments

SESSION 4 - Spatial dynamics and generating immune responses (part 2)

Chairs: Professor Awen Gallimore (Cardiff University, UK) and Dr Berna Bou-Tayeh (University of Oxford, UK)

09:30 | Invited speaker: Professor Gabriele Bergers (KU Leuven, Belgium) 
HEV's and tertiary lymphoid structures in cancer
10:05 | Selected short talk: Suaad Idris (University of Birmingham, UK)
Investigating the cellular dynamics of regulatory CD4 T cell populations in the tumour
10:20 | Selected short talk: Dr Emily Webb (University of Edinburgh, UK) 
Regulation of the anti-tumour immune response by focal adhesion kinase in glioblastoma
10:35 | Selected short talk: Colin Lee (University of Cambridge, UK) 
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate 
local anti-tumour cytolytic activity
10:50 | Invited speaker: Dr Ed Roberts (CRUK Scotland Institute, UK)
Incomplete activation of lymph node resident cDC leads to impaired T cell priming in cancer
11:25 | Poster session 2

12:10 | Lunch and meet the exhibitors

SESSION 5 – Hidden immune players and therapeutic modulation (part 2)

Chairs: Professor Ben Willcox (University of Birmingham, UK) and Dr Silvia Panetti (University of Oxford, UK)

13:00 | Invited speaker: Professor Christoph Scheiermann (University of Geneva, Switzerland)
Circadian anti-tumour immune responses
13:35 | Selected short talk: Muhammet Ali Kara (University of Birmingham, UK)lk
Inducing Antibody Responses Against Angiogenic Markers (Robo4) Restricts Tumour Growth in Solid Tumours
13:50 | Selected short talk: Stav Rabani (Weizmann Institute of Science, Israel)
CD84 as a therapeutic target for breaking immune-tolerance in triple-negative breast cancer          

14:05 | Selected short talk: Dr Ali Roghanian (University of Southampton, UK)  
Therapeutic targeting of the inhibitory FcγRIIB for optimal cancer immunotherapy              

14:20 | Industry sponsored talkDr Alex Liversage (Agilent Technology, UK)  
Tools for functional cell analysis
14:30 | Invited speaker: Professor Adrian Hayday (King’s College London, UK) 
Cancer immunotherapy by gamma delta T cells: nature's CAR-T cells tackle wounds that do not heal
15:05 | Closing remarks and poster prizes


Registration is now open, book your place here.

BSI members benefit from reduced registration fees at this meeting and other BSI events, as well as free access to our journals, grants, career development activities and much more. You can sign up to become a member online. For current BSI members, your reduced fee will be applied automatically if you are logged in to your account. All fees include VAT.

BSI member rate:

 Early bird fees (until midnight on 28 February)Late fees (from 29 February)
Early Career/Clinician in training (read the criteria)£80£90
Postgraduate (anyone studying a PhD or Masters)£50£60*
Senior (retired) (read the criteria)£25£30
Discounted membership/rate (read the criteria£50*£60*
Undergraduate (membership is free)£25£30


Non-member rate:

 Early bird fees (until midnight on 28 February)Late fees (from 29 February)
Early Career/Clinician in training (read the criteria)£130£144
Postgraduate (anyone studying a PhD or Masters)£90£102*
Senior (retired) (read the criteria)£90£102
Discounted membership/rate (read the criteria£90*£102*

*If this fee applies to you, please contact for a discount code prior to registering.

Abstract submission

Abstract submission for this event has now closed.

BSI grants to support your attendance at this event

As part of our career development package, we have two grants available to BSI members to support your attendance at this event. 

  • BSI Regional & Affinity Group Conference Grants: BSI members can apply for up to £100 to contribute towards their travel costs in attending this conference. In this scheme, we have 10 grants available for this conference and they will be allocated on a first come, first served basis to eligible BSI members. Deadline: Thursday 22 February 2024. Find out more and apply.
  • BSI Regional & Affinity Group Carers' Grants: BSI members can apply for up to £100 to contribute towards extra care arrangements costs they incur during the conference, for example, childcare costs, or for additional care for the applicant themselves. Deadline: Thursday 22 February 2024. Find out more and apply.


Thank you to our sponsors who are supporting this event.

Principal sponsors:


If you are interested in sponsoring this event, please contact our Director of Events & Training, Jane Sessenwein, at